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Abstract: Preterm birth is a universal health problem that is one of the largest unmet medical needs
contributing to the global burden of disease. Adding to its complexity is that there are no means
to predict who is at risk when pregnancy begins or when women will actually deliver. Until these
problems are addressed, there will be no interventions to reduce the risk because those who should
be treated will not be known. Considerable evidence now exists that chronic life, generational or
accumulated stress is a risk factor for preterm delivery in animal models and in women. This wear
and tear on the body and mind is called allostatic load. This review explores the evidence that
chronic stress contributes to preterm birth and other adverse pregnancy outcomes in animal and
human studies. It explores how allostatic load can be used to, firstly, model stress and preterm birth
in animal models and, secondly, how it can be used to develop a predictive model to assess relative
risk among women in early pregnancy. Once care providers know who is in the highest risk group,
interventions can be developed and applied to mitigate their risk.
Keywords: allostatic load; allostasis; chronic stress; preterm birth; inflammation; two hits; multiple
hit hypothesis; adverse pregnancy outcomes
1. Introduction
Preterm birth (PTB) is a complex perinatal period health issue that remains one of the greatest
unmet medical challenges. The worldwide rate of PTB is >10% and increasing. Here, we develop a
novel conceptual framework implicating the understudied phenomenon of allostatic load (AL). AL
represents the wear and tear of stress on the mind and body and is both a risk and causal factor for
PTB and possibly other adverse pregnancy outcomes (Figure 1). Its effects can be passed on through
generations leading to poor pregnancy outcomes and adverse developmental trajectories. In this
review, we will link the concept of allostatic load with PTB, describe animal models that generate
both allostatic load and PTB for the study of the problem, and propose a process for developing a tool
based upon allostatic load to stratify women into low and high risk groups for PTB.
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Figure 1. Allostatic load (AL) increases the risk for several perinatal and adult disease processes. 
Allostatic load comprises the wear and tear of stress over a lifetime on the body [1,2]. In chronic stress, 
the allostatic load increases as the body attempts to cope with stressors. When resiliency is overcome, 
inflammatory processes and neuroendocrine mediators, (e.g., cortisol and epinephrine) that normally 
maintain homeostasis now have a negative effect on the body, resulting in increased risk for 
numerous AL disease processes including preterm birth (PTB). 
2. Background 
Preterm birth, which is associated with an intrauterine pro-inflammatory state [3], represents 
the leading cause of neonatal morbidity and mortality and is one of the most critical causal factors 
for disease in later life. For example, infants born preterm (i.e., earlier than 37 completed weeks of 
gestation) are at greater risk of dying before the age of five and for developmental delay and other 
adverse health conditions including cardiovascular and metabolic diseases than infants born at term 
[4]. In spite of focused research efforts, the causes of PTB remain unknown in more than 50% of cases 
[5]. Both severe maternal distress during pregnancy [6,7] or pre-conceptual factors [8] have been 
associated with PTB. 
2.1. Scope of the Issue 
Many reports suggest that adverse perinatal programming by stress may increase the risk of PTB 
and low birth weight [6,7,9]. Prenatal exposure to endocrine disruptors in female rats [10,11] or to 
maternal undernutrition in humans [12] has been associated with increased metabolic and endocrine 
disease risk in the offspring. Gestational stress may affect levels of hormones and neuropeptides, 
including prolactin, progesterone, and oxytocin, which are involved in pregnancy maintenance and 
timing of delivery [13]. In animal studies, adverse experience was suggested to compromise the 
continuation of gestation [14]. 
To date, there is no standard method to measure AL in association with PTB. Typically AL 
assessment is categorized by physiological domains, beginning with the primary neuroendocrine 
mediators, then the secondary outcome domains including immune, metabolic, cardiovascular, 
respiratory and anthropometric, and finally the tertiary outcome domains [15]. Two or three elements 
are measured within each domain to determine a relative score for that domain. Biomarkers within 
these domains are usually systolic and diastolic blood pressure (SBP, DBP), body mass index (BMI), 
serum levels of cortisol, total cholesterol, triglycerides, glucose [16,17], fibrinogen and white blood cell 
count [18]. Other common biomarkers include pro-inflammatory cytokines, especially interleukin 
(IL)-6 [19], and C-reactive protein. More recently, telomere length was suggested as a biomarker of 
allostatic load as it demonstrates cellular aging [20]. Following the evaluation, the results are 
cumulated and ranked on various scales, which then result in an AL score [21]. 
Figure 1. Allostatic load (AL) increases the risk for several perinatal and adult disease processes.
Allostatic load comprises the wear and tear of stress over a lifetime on the body [1,2]. In chronic stress,
the allostatic load increases as the body attempts to cope with stressors. When resiliency is overcome,
inflammatory processes and neuroendocrine mediators, (e.g., cortisol and epinephrine) that normally
maintain homeostasis now have a negative effect on the body, resulting in increased risk for numerous
AL disease processes including preterm birth (PTB).
2. Background
Preterm birth, which is associated with an intrauterine pro-inflammatory state [3], represents
the leading cause of neonatal morbidity and mortality and is one of the most critical causal factors
for disease in later life. For example, infants born preterm (i.e., earlier than 37 completed weeks
of gestation) are at greater risk of dying before the age of five and for developmental delay and
other adverse health conditions including cardiovascular and metabolic diseases than infants born at
term [4]. In spite of focused research efforts, the causes of PTB remain unknown in more than 50%
of cases [5]. Both severe maternal distress during pregnancy [6,7] or pre-conceptual factors [8] have
been associated with PTB.
2.1. Scope of the Issue
Many reports suggest that adverse perinatal programming by stress may increase the risk of PTB
and low birth weight [6,7,9]. Prenatal exposure to endocrine disruptors in female rats [10,11] or to
maternal undernutrition in humans [12] has been associated with increased metabolic and endocrine
disease risk in the offspring. Gestational stress may affect levels of hormones and neuropeptides,
including prolactin, progesterone, and oxytocin, which are involved in pregnancy maintenance and
timing of delivery [13]. In animal studies, adverse experience was suggested to compromise the
continuation of gestation [14].
To date, there is no standard method to measure AL in association with PTB. Typically AL
assessment is categorized by physiological domains, beginning with the primary neuroendocrine
mediators, then the secondary outcome domains including immune, metabolic, cardiovascular,
respiratory and anthropometric, and finally the tertiary outcome domains [15]. Two or three elements
are measured within each domain to determine a relative score for that domain. Biomarkers within
these domains are usually systolic and diastolic blood pressure (SBP, DBP), body mass index (BMI),
serum levels of cortisol, total cholesterol, triglycerides, glucose [16,17], fibrinogen and white blood cell
count [18]. Other common biomarkers include pro-inflammatory cytokines, especially interleukin
(IL)-6 [19], and C-reactive protein. More recently, telomere length was suggested as a biomarker
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of allostatic load as it demonstrates cellular aging [20]. Following the evaluation, the results are
cumulated and ranked on various scales, which then result in an AL score [21].
Though these markers are important in defining allostatic load, they do not gauge social factors
that have been identified as risk factors for PTB. These social markers include socioeconomic status,
past traumatic events, marital or relationship issues, abuse, discrimination, loss of a close friend or
family member and natural disasters. They demonstrate a clear indication of the type and extent of
the stressors that the patient may be experiencing. Many of these factors can be measured through
a variety of tests such as the Adverse Childhood Events (ACE) score [22] or our Wellbeing and
Pregnancy Questionnaire [23]. Another determinant of AL is the epigenetic load of an individual
that accumulates over time or experience [24]. The critical consideration for assessing PTB risk is to
determine which domains and factors within domains provide the best estimate. In addition to the
numerous ways to measure AL, there are at least a dozen methods to compute the composite AL
score [25].
2.2. Our Working Construct
We propose that a composite AL score can predict risk for preterm birth and other adverse
pregnancy outcomes and that this score should include environmental factors, epigenetic inheritance
and the physiological indicators of AL. This derives because these factors are inseparable and
reinforce one another. The following sections examine the evidence that supports this construct.
3. Evidence to Support Construct
3.1. Previous Attempts to Link Allostatic Load with Pregnancy and Birth Outcomes
Several researchers have quantified AL preconception, postpartum and during pregnancy using
an index based on a count of regulatory biomarkers, determined by data availability. Some of
these studies found no evidence of a relationship between maternal preconception AL and adverse
pregnancy outcomes, including PTB or low birth weight [18,26], while others found women with
a history of giving birth to low birth weight infants or PTB had a higher AL [19] (Table 1).
Morrison et al. [27] attempted to determine whether this method of measuring AL during pregnancy
was meaningful. They assessed the distributions of 10 biomarkers in pregnant and non-pregnant
women and found a significant difference in the distribution of each AL-related biomarker. Among
non-pregnant women, the high AL findings were consistent with previous studies (e.g., higher AL in
women who are black, are older, and who have lower incomes). However, these associations were
not present in pregnant women. The authors concluded that their approach to measuring AL may
not provide meaningful information about chronic stress in pregnant women, where AL may reflect
proximal factors in pregnancy more strongly than they represent exposure to chronic stress over a
women’s lifetime.
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Table 1. Methods used to assess allostatic load in association with pregnancy and birth outcomes.
Study Data Source Population Data Collection Biomarkers Allostatic Load Scoring Outcome
Wallace et al., 2013
[26]
Bogalusa Heart
Study
African-American
women Preconception
‚ SBP
‚ DBP
‚ Total cholesterol
‚ Triglycerides
‚ Glucose
‚ Insulin
‚ BMI
‚ Fibrinogen
‚ WBC
Contribution of each biomarker value
to AL index weighted by loadings on
the first principal component. This
linear AL index is split into quartiles
for analysis. Higher quartiles
represent greater AL.
No evidence of a relationship
between maternal preconception
allostatic load and preterm birth or
low birth weight infants.
Wallace et al.,
2013[18]
Bogalusa Heart
Study
African-American
women Preconception
‚ SBP
‚ DBP
‚ Total cholesterol
‚ HDL
‚ LDL
‚ Triglycerides
‚ Glucose
‚ Insulin
‚ Waist circumference
Score of 1 or 0 based on whether
biomarker within high risk percentile
or below based on data sample’s
distribution, respectively. Score is
summed for each biomarker to obtain
AL score ranging from 0 to 9, which
larger score indicated higher AL.
No evidence of a relationship
between maternal preconception
allostatic load and preterm birth or
low birth weight infants.
Wallace and
Harville, 2013 [28]
Tulane-Lakeside
Hospital
Department of
Obstetrics and
Gynecology
White or
African-American
Pregnant: 26–28
weeks gestation
‚ Cholesterol
‚ HbA1c
‚ DHEA-S
‚ Cortisol
‚ SBP
Uses z-score for each biomarker based
on the data sample’s distribution. AL
score for each subject is the sum of
z-scores. Higher scores presents
higher AL.
Gestational age decreased
significantly with increasing
allostatic load.
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Table 1. Cont.
Study Data Source Population Data Collection Biomarkers Allostatic Load Scoring Outcome
Morrison et al.,
2013 [27]
NHANES
1999–2006
Civilian
noninstitutionalized
US population
Pregnant and
non-pregnant
‚ SBP
‚ DBP
‚ 60-s pulse rate
‚ Total cholesterol
‚ HDL-C
‚ CRP
‚ Albumin
‚ Creatinine
‚ HbA1c
‚ Homocysteine
Score of 1 or 0 based on whether
biomarker within high-risk
percentile or below based on data
sample’s distribution, respectively.
Score is summed for each
biomarker to obtain AL score
ranging from 0 to 10, which larger
score indicated higher AL.
AL may reflect proximal factors in
pregnancy more strongly than
they represent exposure to chronic
stress over a woman’s lifetime.
Hux et al.,
2014 [19]
NHANES
1999–2006
Civilian
noninstitutionalized
US population
History of low
birth weight
infants and those
who were preterm
‚ SBP
‚ DBP
‚ Total cholesterol
‚ HDL
‚ HbA1c
‚ CRP
‚ BMI
‚ Albumin
‚ Creatinine
Score of 1 or 0 based on whether
biomarker is within high risk
percentile or below based on data
sample’s distribution, respectively.
Score is summed for each
biomarker to obtain AL score
ranging from 0 to 9, which larger
score indicated higher AL.
Women with history of SGA or
PTB had higher AL than did those
with normal birth weight
outcomes.
29860
Int. J. Mol. Sci. 2015, 16, 29856–29874
3.2. Chronic life Stress in Women
The cumulative effects of stress seem to be of particular importance to PTB risk [9].
Transgenerational and intergenerational stress may contribute to AL as a prognostic factor.
Factors determining PTB risk may be passed on to the offspring through the maternal lineage,
including repeated exposure to stress across generations [28]. Prenatal stress in the offspring, by
permanently altering the inflammatory cytokine milieu, may predispose to pregnancy complications
later in life [29]. Such programming of physiological and inflammatory responses in early
life may transmit through subsequent generations [30]. Inter-generational programming of
hypothalamic-pituitary-adrenal (HPA) axis activity during pre- and early postnatal development
can become a key regulator of adult disease [31,32] and behaviour [33–35]. Thus, maternal stress
during pregnancy may program physiological responses, PTB risk and birth outcomes across
multiple generations.
We assessed chronic, lifelong stressors by designing the Wellbeing and Pregnancy Questionnaire
and relating responses to spontaneous PTB by administering the questionnaire to 223 post-partum
mothers who delivered preterm (75 cases) or at term (148 controls) [23]. Both individual and
contextual variables that influence the stress response were examined. Several checklists designed
for this study and previously validated research instruments were used to measure concepts related
to stress and personal resources. Of all the separate instruments used to construct the questionnaire,
only the Adverse Childhood Experiences (ACE) score [22] was significantly related to spontaneous
PTB (p < 0.05), recording an odds ratio of 1.26 (95% CI 1.08–1.48). When this score was dichotomized
into high (ě2 ACEs) versus low ACE it demonstrated that women with a high ACE score were over
two times more likely to deliver preterm than those who had a score of 0 or 1 (Odds ratio 2.45; 95% CI
1.37–4.38, p < 0.05). Emotional and physical abuse as an adult were not associated with spontaneous
PTB, but when calculating a combined childhood and adult abuse score, composed of the separate
scores for childhood abuse, childhood neglect (from the ACE score) and adult emotional and physical
abuse (from the Adult Assessment Screen [36]), we found a significant association with PTB (p < 0.05).
A composite total stress score of all tools representing stressors or modifiers of the stress response
was calculated as well, which appeared to be significantly related to the risk of spontaneous PTB
(p < 0.05). When comparing a low to a high total stress score, the latter had an even larger OR
than the total stress score itself (1.86 and 1.46 respectively). The presence of depressive symptoms
during pregnancy was also significantly linked to PTB (p < 0.05). When examining more specifically
the relationship between ACE score and spontaneous PTB, we found a direct relation between the
number of ACEs experienced and PTB (χ2 test, p = 0.003). Furthermore, multivariate analysis showed
that, after adjusting for maternal age, educational status, smoking and history of miscarriage, each
additional increment of 1 on the abuse score scale for lifetime abuse increased by 34% the relative risk
for having a spontaneous PTB. Combined, our findings suggest a close relationship between early life
experiences and the PTB risk.
3.3. Animal Models
3.3.1. Stress by Generations
In order to test whether stress to each generation or to an ancestral generation affects pregnancy
and developmental outcomes, we used pregnant Long-Evans rats to show that PTB risk, metabolic,
endocrine and behavioural outcomes were affected by a single exposure to prenatal stress, which was
generated by imposing gestational stress in the F0 parental generation (transgenerational stress) [24]
or by stressing each generation (multigenerational stress) (Figure 2). Stressing each gestating
generation produced a number of adverse pregnancy and newborn outcomes that accumulated with
each succeeding generation. To our great interest we found the same results in the transgenerational
model. The gestating F1 daughters and gestating F2 granddaughters became the generational
longitudinal cohort or lineage. With each generation, prenatal stress (generated in the F0 generation
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in the transgenerational model) gradually reduced gestational length, maternal weight gain during
pregnancy and maternal behavioural activity, and increased the risk of gestational diabetes in
both models. Delayed offspring development was recognizable as early as postnatal day 7, with
the greatest effect in the F3 offspring. Although we observed direct perinatal programming, we
posit that indirect germ-line programming occurred in the F3 generation that were not exposed to
stress unlike F1 (fetuses of F0) or F2 (primordial follicles in fetal ovaries of F1, present during F0
gestation) generations. We propose that gestational stress imposed on the great-maternal generation
in our transgenerational model was passed on via the gametes to modulate gestational length,
pregnancy outcomes and offspring health in the F3 generation. This finding demonstrates genuine
transgenerational programming by stress.
Int. J. Mol. Sci. 2015, 16, page–page 
7 
gre test eff ct in the F3 offs ing. Althou h we obs rved direct peri atal programming, we posit that 
indirect germ-line programming occurred in the F3 generation that were not exposed to stress unlike 
F1 (fetuses of F0) or F2 (primordial follicles in fetal ovaries of F1, present during F0 gestation) 
generations. We propose that gestational stress imposed on the great-maternal generation in our 
transgenerational model was passed on via the gametes to modulate gestational length, pregnancy 
outcomes and offspring health in the F3 generation. This finding demonstrates genuine 
transgenerational programming by stress. 
 
Figure 2. Allostatic load models in pregnant Long-Evans rats. We developed two longitudinal 
models, a multigenerational (left) and a transgenerational model (center), and a single generation (all 
F0) multiple hit model (right) that result in preterm birth plus other adverse pregnancy outcomes. In 
the multigenerational model, pregnant dams in each generation are subjected to restraint and swim 
stresses (S) on gestational day (GD) 12–18. The transgenerational model differs in that only pregnant 
dams from the F0 generation are stressed; their daughters and granddaughters are not stressed (N) 
during their pregnancies. In the multiple hit model, pregnant dams are stressed (S) or not (N) as in 
the longitudinal models plus they receive an intraperitoneal (IP) injection of saline or IL-1β (5 μg/kg) 
daily from GD 17 to delivery. 
3.3.2. Multiple hit Model 
While our intention was to develop a two-hit model, we had yet to solve the question of what 
the second hit should be. Previous literature suggested that male and female offspring of pregnant 
Long-Evans rat dams administered IL-1β from gestational days (GD) 17–21 (term = GD 22.5) had 
impaired cognitive performance (less time spent investigating a novel object) and female offspring 
demonstrated affective behaviour [37]. Maternal IL-1β administration also reduced utilization of 
progesterone in the hippocampus of female offspring as defined by conversion to 
dihydroprogesterone and allopregnanolone. Allopregnanolone plays an important role in the 
development of the central nervous system by promoting neuronal growth early in fetal life and later 
protecting neural development, promoting cognitive function, attenuating anxiety, and attenuating 
the oxytocin release apparatus [38,39]. Substituting restraint stress or chronically administering 
unpredictable stressors to pregnant dams for IL-1β administration also resulted in impaired cognitive 
function in offspring [37,40]. We therefore rationalized that both stress and IL-1β administered 
together might increase AL in pregnant dams and cause them to have more adverse pregnancy 
outcomes including PTB (Figure 2 multiple hit model). This PTB would occur in the F0 generation, 
which did not occur in the multigenerational F0 dams. We found that whereas neither stress alone in 
F0 (naïve) dams nor IL-1β alone had any effect on gestational length or other adverse pregnancy 
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Figure 2. Allostatic load models in pregnant Long-Evans rats. We developed two longitudinal models,
a multigenerational (left) and a transgenerational model (center), and a single generation (all F0)
multiple hit model (right) that result in preterm birth plus other adverse pregnancy outcomes. In
the multigenerational model, pregnant dams in each generation are subjected to restraint and swim
stresses (S) on gestational day (GD) 12–18. T e transgenerational model differs in that only pregnant
dams from t F0 ge eration are stressed; their aughters an granddaughters are ot stressed (N)
during their pregnancies. In the multiple hit model, pregnant dams are stress d (S) or not (N) as in
the longitudinal models plus they receive an intraperitoneal (IP) injection of saline or IL-1β (5 µg/kg)
daily from GD 17 to delivery.
3.3.2. Multiple hit Model
While our intention was to develop a two-hit model, we had yet to solve the question
of what the second hit should be. Previous literature suggested that ale and female
offspring of pregn nt Long-Evans at dams administere IL-1β fr m gestational days (GD) 17–21
(term = GD 22.5) had impaired cognitive perfor ance (less time pent investigating a novel object)
and female offspring demonstrated affective behaviour [37]. Maternal IL-1β administration also
reduced utilization of progesterone in the hippocampus of female offspring as defined by conversion
to dihydroprogesterone and allopregnanolone. Allopregnanolone plays an important role in the
development of the central nervous system by promoting neuronal growth early in fetal life and later
protecting neural development, promoting cognitive function, attenuating anxiety, and attenuating
the oxytocin release apparatus [38,39]. Substituting restraint stress or chronically administering
unpredictable stressors to pregnant dams for IL-1β administration also resulted in impaired cognitive
function in offspring [37,40]. We th ref re rationalized that both stress and IL-1β admin stered
together might increase AL in pregnant dams and cause them to have more advers pregnancy
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outcomes including PTB (Figure 2 multiple hit model). This PTB would occur in the F0 generation,
which did not occur in the multigenerational F0 dams. We found that whereas neither stress alone
in F0 (naïve) dams nor IL-1β alone had any effect on gestational length or other adverse pregnancy
outcome, combining stress with supplementary IL-1β reduced gestational length (the most common
outcome) and increased the number of other adverse pregnancy outcomes (Figure 3). Further, these
two hits also caused poor health outcomes in the offspring, such as delayed brain development and
altered connectivity leading to impaired behavioural performance [41]. Based upon these data, we
propose a “two-hit” hypothesis whereby each significant “hit” by a stressful or inflammatory insult
may cumulatively challenge the intricate mechanisms leading to parturition, thus increasing risk for
preterm birth and other adverse pregnancy outcomes. This is derived from the concept first proposed
by Knudsen [42] who showed that two gene mutations were necessary for retinoblastoma to occur
in a patient. It can be imagined that women experiencing high allostatic load need only another
insult or stress or “hit” to reach the tipping point that leads to an adverse pregnancy outcome. We
hypothesize that more in-depth investigation into the women in our study [23] with two or more
ACEs or life-long abuse, and supposedly already high ALs, would have revealed what these second
hits may have been.
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Figure 3. Adverse pregnancy outcomes in rats; frequency distribution. Two-hit hypothesis. 
Administration of stress (water swimming and restraint from gestational day (GD) 12–18) plus 
interleukin (IL)-1β (5 μg/kg, IP, GD 17-delivery, see Figure 2) to pregnant Long-Evans rats caused 
more pregnant dams to deliver early (most common outcome), deliver late or have other adverse 
pregnancy outcomes (dystocia or fetal resorption) than no treatment control, IL-1β or stress alone. 
These data support the two-hit allostatic load hypothesis [43].  
3.3.3. Stress Hormones and Inflammatory Mediators Intersect at the Placenta: Potential 
Transgenerational Transmission Mechanism 
Exposure of a fetus to glucocorticoids (GCs) during maternal stress is regulated, in part, by the 
placental enzyme 11β-hydroxysteroid dehydrogenase types 1 and 2 (11βHSD1/2). Circulating levels 
of physiological GC are much higher in the maternal than fetal blood. This gradient is ensured by 
11βHSD2 which catalyzes the rapid inactivation of GCs to their inert 11-keto forms, thus forming a 
natural barrier to maternal GCs [44,45]. Maternal stress downregulates the feto-placental 11βHSD2 
gene [46] and thereby excess GC levels caused by severe maternal stress may pass the placenta to 
reach the fetus [47,48]. A number of groups including ours have found that inflammatory mediators, 
including interleukins (ILs), decrease activity of 11βHSD2 whereas prostaglandins (PGs) increase the 
activity or expression of its counterpart, 11βHSD1, which promotes metabolism of cortisone to active 
GC [3,49]. Excess GCs may stimulate fetal membrane PG production [50,51] which upregulates 
11βHSD1, and PGs and cytokines are mutually stimulatory (Figure 4). Thus, excessive maternal GCs, 
cytokines or PGs can lead to 11βHSD2 inhibition/11βHSD1 activation thereby increasing fetal GC 
concentrations that modulate the developing fetal HPA axis and its regulation in later life, altering 
brain development and HPA axis functions throughout the life course [52] including changes in 
memory and behaviour [48]. In this way, it is possible that stress in one generation may affect the 
next leading to a number of adverse outcomes including several associated with pregnancy and 
development. 
Figure 3. Adverse pregnancy outcomes in rats; frequency distribution. Two-hit hypothesis.
Administration of stress (water swimming and restraint from gestational day (GD) 12–18) plus
interleukin (IL)-1β (5 µg/kg, IP, GD 17-delivery, see Figure 2) to pregnant Long-Evans rats caused
more pregnant dams to deliver early (most common outcome), deliver late or have other adverse
pregnancy outcomes (dystocia or fetal resorption) than no treatment control, IL-1β or stress alone.
These data support the two-hit allostatic load hypothesis [43].
3.3.3. Stress Hormones and Inflammatory Mediators Intersect at the Placenta: Potential
Transgenerational Transmission Mechanism
Exposure of a fetus to glucocorticoids (GCs) during maternal stress is regulated, in part, by the
placental enzyme 11β-hydroxysteroid dehydrogenase types 1 and 2 (11βHSD1/2). Circulating levels
of physiological GC are much higher in the maternal than fetal blood. This gradient is ensured by
11βHSD2 which catalyzes the rapid inactivation of GCs to their inert 11-keto forms, thus forming a
natural barrier to maternal GCs [44,45]. Maternal stress downregulates the feto-placental 11βHSD2
gene [46] a d th r by excess GC lev ls caused by severe maternal tress may pa s the placenta to
reach the fetus [47,48]. A number of groups including ours have found that inflammatory mediators,
including interleukins (ILs), decrease activity of 11βHSD2 whereas prostaglandins (PGs) increase
the activity or expression of its counterpart, 11βHSD1, which promotes metabolism of cortisone to
active GC [3,49]. Excess GCs may stimulate fetal membrane PG production [50,51] which upregulates
11βHSD1, and PGs and cytokines are mutually stimulatory (Figure 4). Thus, excessive maternal GCs,
cytokines or PGs can lead to 11βHSD2 inhibition/11βHSD1 activation thereby increasing fetal GC
concentrations that modulate the developing fetal HPA axis and its regulation in later life, altering
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brain development and HPA axis functions throughout the life course [52] including changes in
memory and behaviour [48]. In this way, it is possible that stress in one generation may affect
the next leading to a number of adverse outcomes including several associated with pregnancy
and development.
3.3.4. Epigenetic Associations
Our striking phenotypic impairments in the F3 generation suggest a genuine ancestral
epigenetic inheritance whereby the epigenetic modifications have been passed via the gametes
whose epigenome escaped reprogramming [53,54]. Indeed, phenotypic findings in behaviour and
physiology were supported by molecular changes involving epigenetic regulation of gene expression
whereby ancestral stress altered microRNA (miR or miRNA) expression patterns in brain and uterus
of non-pregnant, lactating F2 mothers. In particular, stress led to upregulation of miR-200b and
downregulation of miR-429, which may modulate gestational length. When upregulated, miR-200b
may suppress transcription factors Stat5b, Zeb1 and Zeb2 mRNA levels in the lineage of pregnant
dams exposed to prenatal stress. Furthermore, stress also increased miR-181a expression in the
placenta. miR-181a has been associated with PTB in humans and may serve as a marker of shortened
gestation [36]. These and other observations suggest that stress leads to miRNA changes in brain [55],
uterus and placenta [24] and that the mechanisms involved in the timing of parturition and associated
behavioural and physiological signatures may be programmed through the maternal lineage. The
identification of epigenetic signatures of PTB in clinically accessible tissues, particularly maternal
leukocytes but possibly placenta, offers the potential for predictive and preventive studies related to
poor pregnancy outcomes.
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Figure 4. Role of placenta in transmission of generational stressors from mother to fetus. Increased 
fetal cortisol can be derived from elevated maternal cortisol concentrations via a high concentration 
gradient plus maternal cortisol-induced stimulation of corticotrophin releasing hormone (CRH) and 
prostaglandins (PGs) in placenta and fetal membranes. PGF2α in turn stimulates 11β-hydroxysteroid 
dehydrogenase type 1 (11βHSD1) that converts the less biologically active cortisone to cortisol. 
Further, CRH and PGF2α can stimulate cytokine production, and in turn cytokines stimulate CRH 
and PGF production. Several cytokines, including IL-1β, inhibit the enzyme, 11βHSD2, which 
converts cortisol to cortisone, thereby decreasing the metabolism of cortisol. The net effect of 
increased activity of 11βHSD1 and decreased 11βHSD2 activity is an increased cortisol gradient and 
reduced metabolism leading to higher concentrations of fetal cortisol. Maternal cytokines can 
stimulate the production of fetal cytokines directly through cytokine stimulation and indirectly 
through CRH and PGF2α. Increased cortisol and cytokines in the fetal compartment amplify the 
production of more fetal cytokines, PGs and CRH and permit more cortisol to cross the placenta 
thereby increasing fetal circulating cortisol concentrations. Legend: Green arrows stimulatory; red 
curved arrows inhibitory, straight maroon and blue arrows passage through placenta. 
The mechanism for transgenerational inheritance of epigenetic information from mother to 
offspring remains uncertain although strong evidence exists for it (extensively reviewed in Babenko et al. 
[56]). Recent discoveries indicate that the placenta releases miRNAs, either directly into the maternal 
and fetal circulation or encapsulated into exosomes, and that maternal miRNAs can pass through the 
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fetal cortisol can be derived from elevated maternal cortisol concentrations via a high concentration
gradient plus maternal cortisol-induced stimulation of corticotrophin releasing hormone (CRH) and
prostaglandins (PGs) in placenta and fetal membranes. PGF2α in turn stimulates 11β-hydroxysteroid
dehydrogenase type 1 (11βHSD1) that converts the less biologically active cortisone to cortisol.
Further, CRH and PGF2α can stimulate cytokine production, and in turn cytokines stimulate CRH
and PGF production. Several cytokines, including IL-1β, inhibit the enzyme, 11βHSD2, which
converts cortisol to cortisone, thereby decreasing the metabolism of cortisol. The net effect of increased
activity of 11βHSD1 and decreased 11βHSD2 activity is an increased cortisol gradient and reduced
metabolism leading to higher concentrations of fetal cortisol. Maternal cytokines can stimulate the
production of fetal cytokines directly through cytokine stimulation and indirectly through CRH and
PGF2α. Increased cortisol and cytokines in the fetal compartment amplify the production of more
fetal cytokines, PGs and CRH and permit more cortisol to cross the placenta thereby increasing fetal
circulating cortisol concentrations. Legend: Green arrows stimulatory; red curved arrows inhibitory,
straight maroon and blue arrows passage through placenta.
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The mechanism for transgenerational inheritance of epigenetic information from mother
to offspring remains uncertain although strong evidence exists for it (extensively reviewed in
Babenko et al. [56]). Recent discoveries indicate that the placenta releases miRNAs, either directly
into the maternal and fetal circulation or encapsulated into exosomes, and that maternal miRNAs can
pass through the placenta to the fetus [49–51]. This could be another method of transgenerational
transfer of stress effectors from mother to fetus as well as possible predictive biomarkers.
3.3.5. Stress, Inflammatory Mediators and Preterm Birth
We have developed, tested and confirmed a robust pathway scheme that leads from several
different causes of PTB to the transformation of the uterus from pregnancy to active labour
(Figure 5) based upon the literature and our own experiments. Parturition is the transition
from the pro-pregnancy and anti-inflammatory state to the pro-labour, pro-inflammatory state.
Inflammatory processes play significant roles in most, if not all, labours, regardless of the presence
of infection, etiology, or timing of delivery [57,58]. Inflammatory processes activate parturition and
are intertwined with early (upstream), mid (midstream), and late (downstream) events in the birth
cascade. Toll-like receptors (TLRs) are identified as upstream mediators of inflammatory cytokine and
chemokine synthesis in both infection-induced PTB and normal delivery [59]. A receptor family that
binds pathogen-associated molecular patterns (PAMPs) or damage-associated pathogens (DAMPs),
the TLRs are expressed in the maternal decidua and during gestation in placental trophoblasts and
membranes [59,60]. Upon activation they elicit pro-inflammatory cytokine and chemokine expression
(e.g., IL-1β, IL-6, etc.), which are early mediators of the inflammatory response. Inflammatory
cytokines activate and attract leukocytes from the peripheral blood into the uterus [61]. As more
leukocytes invade the uterus, midstream events, including expression changes in uterine activation
proteins (UAPs) and cellular adhesion molecules (CAMs) occur. The latter bind and tether the
infiltrating leukocytes to create an inflammatory microenvironment [62] in which the inflammatory
response is amplified through the release of pro-inflammatory cytokines, corticotrophin releasing
hormone (CRH), and PGs, causing further expression of UAPs, cytokines, chemokines, and PGs,
thereby transforming the uterus of pregnancy to the uterus of labour [57].
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Figure 5. Inflammatory cascade leading to preterm birth. Stress, infection and other initiators 
stimulate Toll-like receptors (TLRs) to produce cytokines and chemokines that stimulate peripheral 
leukocytes to infiltrate the uterus. In turn, this leads to further stimulation of cytokines and 
chemokines plus the production of prostaglandins (PGs), matrix metalloproteinases (MMPs), and 
uterine activation proteins such as connexin-43 (CX-43), the PGF receptor (PTGFR) and the oxytocin 
receptor (OTR). The expression of these and many other proteins transform the uterus of pregnancy 
to the uterus of delivery via stimulating the physiological changes in myometrial contractility, 
membrane rupture and cervical ripening. 
Drawing together these diverse elements (multi- and transgenerational stress, multiple hits, 
inflammatory mediators, and uterine transformation for labour) and their individual and combined 
effects upon adverse pregnancy and developmental outcomes should hopefully provide new insights 
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leukocytes to infiltrate the uterus. In turn, this leads to further stimulation of cytokines and
chemokines plus the production of prostaglandins (PGs), matrix metalloproteinases (MMPs), and
uterine activation proteins such as connexin-43 (CX-43), the PGF receptor (PTGFR) and the oxytocin
receptor (OTR). The expression of these and many other proteins transform the uterus of pregnancy
to the uterus of delivery via stimulating the physiological changes in myometrial contractility,
membrane rupture and cervical ripening.
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Drawing together these diverse elements (multi- and transgenerational stress, multiple hits,
inflammatory mediators, and uterine transformation for labour) and their individual and combined
effects upon adverse pregnancy and developmental outcomes should hopefully provide new insights
into mechanisms, means to diagnose risk and new therapies to treat them. We next explore allostasis
and allostatic load as unifying concepts in this regard.
4. Allostasis and Allostatic Load
4.1. Definitions
Originally proposed in the late 1980s by Sterling and Eyer, allostasis is the adaptive process
for actively maintaining stability through change [1]. Allostasis is derived from the Greek “allo”,
meaning “variable”, while “stasis” means “stand”. It is the way in which the body maintains
homeostasis when exposed to stressors. It involves the stress response along with the production
of inflammatory cytokines, adrenal hormones and neurotransmitters that help us adapt to new
situations and challenges [2,63,64]. The brain plays a central role in allostasis by controlling
various mechanisms simultaneously. In acute situations, allostasis is beneficial for the body, as it is
essential for the body to respond and adapt to stressors. However, when allostasis is prolonged—in
chronic or repetitive stress (called “hits” according to the Knudson multiple hit hypothesis [42])—the
autonomic nervous system and HPA axis are repetitively activated and the neuroendocrine (cortisol,
epinephrine, norepinephrine, dopamine) and inflammatory adaptive processes can now create
damage through precipitating diseases including PTB. For this, McEwen adapted the term “allostatic
load”. [65], defined as the cumulative results of allostasis. In other words, it comprises the wear
and tear of allostasis over a lifetime on the body and the brain [17]. Allostatic load can therefore
increase inflammatory cells and cytokines in tissues and cause increased susceptibility to infection
and inflammation and many other adverse health conditions [2,66,67].
4.2. Types of Stressors
We propose categorizing stressors or hits into major groups, organized around transgenerational
stressors, the genetic and epigenetic predisposition, early life stressors including in utero events, social
context, life-long stress exposure, the response to stressors including behavioural, psychological
and inflammatory, and also the epigenetic signature that results from these life experiences.
Daskalakis [68] argues that within a given context vulnerability is enhanced with three hits and failure
to cope with adversity accumulates. These three hits are the (epi)genetic predisposition existing at
the time of conception (i.e., the (epi)genetic inheritance from both parents), earlylife environment,
including in utero and the first year of life, and later-life environment, both having a large epigenetic
component. These susceptibilities, as suggested by Saban et al. [69], could lead to a pro-inflammatory
epigenetic signature that bridges the psycho-social environment and tilts the individual towards
disease vulnerability. We have integrated the concept of Saban et al. [69] and our own data into
a conceptual framework that illustrates how multiple hits involving generational and life-course
experience lead to allostatic load and PTB (Figure 6).
4.3. Our Conceptual Framework
Based upon concepts by Saban et al. [69], the Allostatic Load and Preterm Birth Conceptual
Framework (Figure 6) asserts that an individual acquires generational experience through its
genetic and epigenetic inheritance. This includes transgenerational inheritance via its germ cells
or via placental transfer (e.g., of miRNA [70]) or by placental transfer of stress hormones and
mediators (Figure 4). Early life adversity can occur in utero as well as in the newborn and early
childhood periods, while social context and stress exposure are also major contributors to allostatic
load. Allostasis is the response to these experiences including the behavioural, psychological
and inflammatory. As the allostatic load exceeds the ability to cope, the risk for PTB or other
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adverse pregnancy or developmental outcomes increases likely through activation of inflammatory,
epigenetic, hormonal and/or neurotransmitter pathways. In the case of PTB, these mechanisms
include increased invasion of the uterus by leukocytes plus increased cytokine, chemokine, PG and
matrix metalloproteinase output, stimulation of uterine activation gene expression and finally labour
and delivery.
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Figure 6. Conceptual framework linking transgenerational allostatic load and preterm birth. Building 
from the model of Saban et al. [69] and our own experimental data, we developed the Allostatic Load 
and Preterm Birth Conceptual Framework. This model provides a context for generational 
programming in connection with genetic and epigenetic signatures, multiple “hits” or stressors 
throughout the life course, downstream responses to these stressors leading to high allostatic load, 
and ultimately a sequence of distinct inflammatory and other mediator responses that lead to uterine 
activation, transformation and preterm birth (refer to Figure 5). The consequences of these effects are 
passed on to the next generation. See text for detailed description. 
4.4. Experimental Models of Allostatic Load and PTB 
Most studies and reviews of allostatic load and adverse health outcomes emphasize the 
longitudinal nature of accumulated lifetime or transgenerational stress [15,65,69,71]. In our studies, 
we observed increases in plasma corticosterone, the active glucocorticoid in the rat, with each 
generation in both transgenerational and multigenerational models. Increases in circulating 
glucocorticoids, neurotransmitters (e.g., dopamine, epinephrine or norepinephrine), and anti-
inflammatory cytokines (e.g., interleukin-6) are described by Read and Grundy as the primary 
mediators of allostatic load [15]. Stress leading to increased neuroendocrine mediators sets off an 
accumulation of events leading to secondary outcomes including altered metabolism and metabolic 
indicators (e.g., insulin, glucose, total cholesterol, triglycerides, visceral fat depositing), 
cardiovascular indicators (e.g., systolic and diastolic blood pressure) and inflammatory proteins (e.g., 
C-reactive protein, fibrinogen). We observed hyperglycemia and decreased maternal weight—
evidence of a metabolic disturbance likely due to gluconeogenesis—in both models. Tertiary 
outcomes are the result of the primary and secondary events and are the most easily observable 
health outcomes. In this model, they include changes in maternal behaviour and pregnancy 
outcomes. Read and Grundy observed the effects of allostatic load and health in an older population. 
They found that allostatic load predicted slower walking speed. Our observations extended further 
into the following generation and thus suggest an extension of their concept. We propose that the 
transgenerational passage of adverse health outcomes to the offspring should also be included among 
the tertiary outcomes. In this sense, we observed the tertiary outcomes of altered F0 maternal 
behaviours (decreased tail chasing and decreased exploratory activity) and delayed F1 offspring 
neurodevelopment (decreased negative geotaxis and reduced cortical neuronal density) plus changes 
in miRNAs, a marker of epigenetic change. Later in life, the F1 daughters in both the 
transgenerational and multigenerational models had an increased incidence of preterm delivery, and 
with each subsequent generation the primary, secondary and tertiary domains of allostatic load 
became more exaggerated [24,41]. In terms of human studies, our work in a cohort of Canadian 
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from the model of Saban et al. [69] and our own experimental data, we developed the Allostatic
Load and Preterm Birth Conceptual Framework. This model provides a context for generational
programming in connection with genetic and epigenetic signatures, multiple “hits” or stressors
throughout the life course, downstream responses to these stressors leading to high allostatic load,
and ultimately a sequence of distinct inflammatory and other mediator responses that lead to uterine
activation, transformation and preterm birth (refer to Figure 5). The consequences of these effects are
passed on to the next generation. See text for detailed description.
4.4. Experimental Models of Allostatic Load and PTB
Most studies and reviews of allostatic load and adverse health outcomes emphasize the
longitudinal nature of accumulated lifetime or transgenerational stress [15,65,69,71]. In our
studies, we observed increases in plasma corticosterone, the active glucocorticoid in the rat,
with each generation in both transgenerational and multigenerational models. Increases in
circulating glucocorticoids, neurotransmitters (e.g., dopamine, epinephrine or norepinephrine),
and anti-inflammatory cytokines (e.g., interleukin-6) are described by Read and Grundy as the
primary mediators of allostatic load [15]. Stress leading to increased neuroendocrine mediators
sets off an accumulation of events leading to secondary outcomes including altered metabolism and
metabolic indicators (e.g., insulin, glucose, total cholesterol, triglycerides, visceral fat depositing),
cardiovascular indicators (e.g., systolic and diastolic blood pressure) and inflammatory proteins
(e.g., C-reactive protein, fibrinogen). We observed hyperglycemia and decreased maternal
weight—evidence of a metabolic disturbance likely due to gluconeogenesis—in both models. Tertiary
outcomes are the result of the primary and secondary events and are the most easily observable health
outcomes. In this model, they include changes in maternal behaviour and pregnancy outcomes.
Read and Grundy observed the effects of allostatic load and health in an older population. They
found that allostatic load predicted slower walking speed. Our observations extended further
into the following generation and thus suggest an extension of their concept. We propose that
the transgenerational passage of adverse health outcomes to the offspring should also be included
among the tertiary outcomes. In this sense, we observed the tertiary outcomes of altered F0
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maternal behaviours (decreased tail chasing and decreased exploratory activity) and delayed F1
offspring neurodevelopment (decreased negative geotaxis and reduced cortical neuronal density)
plus changes in miRNAs, a marker of epigenetic change. Later in life, the F1 daughters in both
the transgenerational and multigenerational models had an increased incidence of preterm delivery,
and with each subsequent generation the primary, secondary and tertiary domains of allostatic load
became more exaggerated [24,41]. In terms of human studies, our work in a cohort of Canadian
women [23] demonstrated that adverse childhood experience prior to the age of 18 or life-long abuse
are associated with PTB at an average age of 28.
However, the theory of acquiring allostatic load does not need to be restricted to life-long or
transgenerational accumulation of stress. Allostatic load can also be achieved by an accumulation
of stressors over a short duration of time. We demonstrated this using our multiple hit model
(Figures 2 and 3) whereby combining stress plus administration of the pro-inflammatory cytokine,
IL-1β, led to PTB and other adverse pregnancy outcomes whereas neither stress nor IL-1β alone
affected pregnancy outcomes in F0 rat dams. The multiple hit theory [72] has been used to explain
epilepsy [73] and schizophrenia [74] among other diseases. Mor’s group exposed the mouse to a viral
infection at the time of implantation, which increased the sensitivity of maternal immune cells to later
bacterial infection and PTB [75].
While our data are limited at this writing, we have observed similar changes in primary,
secondary and tertiary outcomes in our two-hit model as in our longitudinal generational models
and hope soon to confirm that the multiple hit model mimics the longitudinal models. From the
lessons learned regarding allostatic load markers for PTB in these animal models and the retrospective
analysis of human data, our goal will be to develop a predictive model highly specific for assessing
PTB risk in women during early pregnancy in order to identify those in the highest risk group who
would be candidates for interventions to mitigate their risk.
4.5. Using Allostatic Load to Predict PTB Risk
Allostatic load markers have the potential to be incorporated into an effective risk model for
PTB and other adverse pregnancy outcomes because they assess and integrate multiple systems.
It is an index of multisystem physiologic risk that is used as a measure of the cumulative toll of
physiologic and psychological stress [76]. It assumes multisystemic interactions and incorporates
subclinical biomarkers of neuroendocrine, inflammatory, and metabolic function into a single index
score [25]. Allostatic load is higher in marginalized populations and is associated with many adverse
health outcomes; therefore, it may be a better predictor of adverse pregnancy outcome than traditional
individual measures [18,65,77–80]. In the existing literature (e.g., Table 1) for allostatic load and
PTB, two studies from the same group but using different non-specific markers of allostatic load
before conception indicate there is no relationship between allostatic load and PTB [18]. But when
the same authors used allostatic load markers more specific for PTB, they observed a significant
relationship between elevated allostatic load and decreased gestation length [81]. In a retrospective
study, specific allostatic load assessment had higher scores for women who delivered preterm than the
term gestation reference group (p = 0.001); a similar outcome was noted when preeclampsia was the
outcome measure [19,21]. Hence if the appropriate time points during pregnancy and allostatic load
markers are selected, allostatic load has high potential to be an effective and relatively straightforward
marker of PTB risk.
5. Developing an Allostatic Load Model for Predicting PTB Risk
We started searching for applications of allostatic load to predicting disease risk by searching
PubMed (August 2015) for articles using the search term allostatic load. This generated 808 articles.
We systematically scanned the titles and abstracts of these articles and chose those most relevant.
Upon reviewing them, we established a working definition of allostatic load and its assessment.
Next we narrowed the scope of our search to allostatic load and pregnancy. This search resulted in
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27 papers that included one on preeclampsia and three on PTB. After reading each relevant article
in detail, we narrowed the search to allostatic load and preterm birth, which generated 13 results,
and incorporated the relevant articles. We then compared the PTB literature to other health problems
involving allostatic load including preeclampsia, cancer and multiple psychological disorders [82,83].
We will use our conceptual framework of allostatic load and PTB (Figure 6) as a guide and apply
it to the process of concept analysis to build the predictive model. This is a tool first developed
in mathematics [84,85] and then applied successfully in nursing science [86]. It relates concepts to
observations through question formation to establish the defining characteristics of the theory. The
observations can be literature examples or experimental results, which are called case studies. By
iteratively linking questions with case studies, the model takes shape. Typically a conclusive model
does not result from concept analysis, but instead an assumed conclusion is formed that leads to
suggestions for further research and a refinement of the model [86]. Hence the working theoretical
model that results is constantly evolving, improving with each iteration of the research cycle. The
tool can be applied at any time for solving a complex health problem, but it will continue to evolve
and improve.
We are just beginning to develop a prognostic test for PTB. Because of the ability of allostatic
load to affect multiple systems, it can be hypothesized that it contributes to the pathogenesis of PTB
and thus would be an appropriate tool to assess PTB risk. Future research into this area will need
to ask (1) which markers of allostatic load predict PTB best; (2) whether allostatic load measured in
pregnancy is associated with increased odds of delivering preterm; (3) how early in pregnancy or
pre-conceptually can allostatic load be measured and associated with PTB risk; (4) whether tailored
allostatic load models need to be developed for varying cultures, jurisdictions and environments; and
(5) whether allostatic load models specific for preterm birth are better at predicting PTB than other
adverse pregnancy outcomes such as preeclampsia or gestational diabetes [24,41,87,88].
6. Conclusions
The future of research in the field of women’s pregnancy health and perinatal health in general
will be at the population and clinical level and the study of allostatic load will be a leader in this effort.
But the way in which population and clinical health research are addressed will be quite different than
in the past. First, at this time there is too little reliance upon animal models that inform about basic
mechanisms when framing clinical and epidemiological questions. Animal models of allostatic load
will provide new evidence upon which to frame questions in the human context. Secondly, instead
of the retrospective approach, the workhorse of epidemiological inquiry, research at the population
and clinical levels involving the principles of allostatic load, gleaned from basic studies, will be
prospective in order to predict women at risk of adverse pregnancy outcomes. The process of concept
analysis may permit fewer women to be recruited into studies while retaining adequate power due
to its iterative nature. The bane of PTB prospective trials when it is not known who is at risk is the
large number of subjects required. Concept analysis will be used in a constantly evolving, iterative
fashion testing predictive concepts in human cohorts thereby developing the algorithms required to
ultimately and as quickly as possible identify women in the highest risk groups so that they can
receive appropriate care to mitigate their pregnancy risks.
Acknowledgments: The authors are grateful to Ashlee Matkin and Erin Falkenberg for assistance with the rat
experiments, to Amanda McRoberts for providing many figures, and to Jane Kondejewski for expert editorial
services. The authors acknowledge support by the Canadian Institutes of Health Research, the National
Science and Engineering Research Council of Canada, Alberta Innovates-Health Solutions, The Research
Foundation—Flanders (FWO), The University of Ghent, and the Molly Towell Perinatal Research Foundation.
Author Contributions: David M. Olson was the primary author with considerable writing contributions from
Emily M. Severson and Gerlinde A. S. Metz. J. Keiko McCreary provided data and a writing contribution, Barbara
S. E. Verstraeten provided a significant writing contribution and, along with Jane W. Y. Ng, considerable expert
opinion and editorial services.
Conflicts of Interest: The authors declare no conflict of interest.
29869
Int. J. Mol. Sci. 2015, 16, 29856–29874
References
1. Sterling, P.; Ever, J. Allostasis: A New Paradigm to Explain Arousal Pathology; Fisher, S.J.R., Ed.; John Wiley &
Sons: New York, NY, USA, 1988.
2. McEwen, B.S. Protective and damaging effects of stress mediators. N. Engl. J. Med. 1998, 338, 171–179.
[PubMed]
3. Christiaens, I.; Zaragoza, D.B.; Guilbert, L.; Robertson, S.A.; Mitchell, B.F.; Olson, D.M. Inflammatory
processes in preterm and term parturition. J. Reprod. Immunol. 2008, 79, 50–57. [CrossRef] [PubMed]
4. Mikkola, K.; Ritari, N.; Tommiska, V.; Salokorpi, T.; Lehtonen, L.; Tammela, O.; Pääkkönen, L.; Olsen, P.;
Korkman, M.; Fellman, V. Neurodevelopmental outcome at 5 years of age of a national cohort of extremely
low birth weight infants who were born in 1996–1997. Pediatrics 2005, 116, 1391–1400. [CrossRef] [PubMed]
5. Kramer, M.S.; Lydon, J.; Goulet, L.; Kahn, S.; Dahhou, M.; Platt, R.W.; Sharma, S.; Meaney, M.J.; Séguin, L.
Maternal stress/distress, hormonal pathways and spontaneous preterm birth. Paediatr. Perinat. Epidemiol.
2013, 27, 237–246. [CrossRef] [PubMed]
6. Hobel, C.J. Stress and preterm birth. Clin. Obstet. Gynecol. 2004, 47, 856–880. [CrossRef] [PubMed]
7. Zhu, P.; Tao, F.; Hao, J.; Sun, Y.; Jiang, X. Prenatal life events stress: Implications for preterm birth and infant
birthweight. Am. J. Obstet. Gynecol. 2010, 203, 34.e1–34.e8. [CrossRef] [PubMed]
8. Emanuel, I.; Leisenring, W.; Williams, M.A.; Kimpo, C.; Estee, S.; O’Brien, W.; Hale, C.B. The Washington
State Intergenerational Study of Birth Outcomes: Methodology and some comparisons of maternal
birthweight and infant birthweight and gestation in four ethnic groups. Paediatr. Perinat. Epidemiol. 1999,
13, 352–369. [CrossRef] [PubMed]
9. Rich-Edwards, J.W.; Grizzard, T.A. Psychosocial stress and neuroendocrine mechanisms in preterm
delivery. Am. J. Obstet. Gynecol. 2005, 192, S30–S35. [CrossRef] [PubMed]
10. Nilsson, E.E.; Anway, M.D.; Stanfield, J.; Skinner, M.K. Transgenerational epigenetic effects of the endocrine
disruptor vinclozolin on pregnancies and female adult onset disease. Reproduction 2008, 135, 713–721.
[CrossRef] [PubMed]
11. Skinner, M.K.; Manikkam, M.; Tracey, R.; Guerrero-Bosagna, C.; Haque, M.; Nilsson, E.E. Ancestral
dichlorodiphenyltrichloroethane (DDT) exposure promotes epigenetic transgenerational inheritance of
obesity. BMC Med. 2013, 11, 228. [CrossRef] [PubMed]
12. Veenendaal, M.V.; Painter, R.C.; de Rooij, S.R.; Bossuyt, P.M.; van der Post, J.A.; Gluckman, P.D.;
Hanson, M.A.; Roseboom, T.J. Transgenerational effects of prenatal exposure to the 1944–45 Dutch famine.
BJOG 2013, 120, 548–553. [CrossRef] [PubMed]
13. Miller, A.E.; Riegle, G.D. Progesterone and luteinizing hormone secretion following stress-induced
interruption of constant estrus in aged rats. J. Gerontol. 1985, 40, 129–132. [CrossRef] [PubMed]
14. Arck, P.C. Stress and pregnancy loss: Role of immune mediators, hormones and neurotransmitters. Am. J.
Reprod. Immunol. 2001, 46, 117–123. [CrossRef] [PubMed]
15. Read, S.; Grundy, E. Allostatic load—A challenge to measure multisystem physiological regulation working
paper. Available online: http://eprints.ncrm.ac.uk/2879/1/NCRM_workingpaper_0412.pdf (accessed on
24 August 2015).
16. McEwen, B.S.; Seeman, T. Protective and damaging effects of mediators of stress. Elaborating and testing
the concepts of allostasis and allostatic load. Ann. N. Y. Acad. Sci. 1999, 896, 30–47. [CrossRef] [PubMed]
17. Hoffman, C.L.; Higham, J.P.; Heistermann, M.; Coe, C.L.; Prendergast, B.J.; Maestripieri, D. Immune
function and HPA axis activity in free-ranging rhesus macaques. Physiol. Behav. 2011, 104, 507–514.
[CrossRef] [PubMed]
18. Wallace, M.; Harville, E.; Theall, K.; Webber, L.; Chen, W.; Berenson, G. Neighborhood poverty, allostatic
load, and birth outcomes in African American and white women: Findings from the Bogalusa Heart Study.
Health Place 2013, 24, 260–266. [CrossRef] [PubMed]
19. Hux, V.J.; Catov, J.M.; Roberts, J.M. Allostatic load in women with a history of low birth weight infants:
The national health and nutrition examination survey. J. Women’s Health 2014, 23, 1039–1045. [CrossRef]
[PubMed]
20. Franceschi, C.; Campisi, J. Chronic inflammation (inflammaging) and its potential contribution to
age-associated diseases. J. Gerontol. A Biol. Sci. Med. Sci. 2014, 69, S4–S9. [CrossRef] [PubMed]
29870
Int. J. Mol. Sci. 2015, 16, 29856–29874
21. Hux, V.J.; Roberts, J.M. A potential role for allostatic load in preeclampsia. Matern. Child Health J. 2014, 19,
591–597. [CrossRef] [PubMed]
22. Felitti, V.J.; Anda, R.F.; Nordenberg, D.; Williamson, D.F.; Spitz, A.M.; Edwards, V.; Koss, M.P.; Marks, J.S.
Relationship of childhood abuse and household dysfunction to many of the leading causes of death in
adults. The Adverse Childhood Experiences (ACE) Study. Am. J. Prev. Med. 1998, 14, 245–258. [CrossRef]
23. Christiaens, I.; Hegadoren, K.; Olson, D.M. Adverse childhood experiences are associated with spontaneous
preterm birth:A case-control study. BMC Med. 2015. in press. [CrossRef] [PubMed]
24. Yao, Y.; Robinson, A.M.; Zucchi, F.C.; Robbins, J.C.; Babenko, O.; Kovalchuk, O.; Kovalchuk, I.; Olson, D.M.;
Metz, G.A.S. Ancestral exposure to stress epigenetically programs preterm birth risk and adverse maternal
and newborn outcomes. BMC Med. 2014, 12, 121. [CrossRef] [PubMed]
25. Juster, R.P.; McEwen, B.S.; Lupien, S.J. Allostatic load biomarkers of chronic stress and impact on health
and cognition. Neurosci. Biobehav. Rev. 2010, 35, 2–16. [CrossRef] [PubMed]
26. Wallace, M.; Harville, E.; Theall, K.; Webber, L.; Chen, W.; Berenson, G. Preconception biomarkers
of allostatic load and racial disparities in adverse birth outcomes: The Bogalusa Heart Study.
Paediatr. Perinat. Epidemiol. 2013, 27, 587–597. [CrossRef] [PubMed]
27. Morrison, S.; Shenassa, E.D.; Mendola, P.; Wu, T.; Schoendorf, K. Allostatic load may not be associated with
chronic stress in pregnant women, NHANES 1999–2006. Ann. Epidemiol. 2013, 23, 294–297. [CrossRef]
[PubMed]
28. Porter, T.F.; Fraser, A.M.; Hunter, C.Y.; Ward, R.H.; Varner, M.W. The risk of preterm birth across
generations. Obstet. Gynecol. 1997, 90, 63–67. [CrossRef]
29. Coussons-Read, M.E.; Lobel, M.; Carey, J.C.; Kreither, M.O.; D’Anna, K.; Argys, L.; Ross, R.G.; Brandt, C.;
Cole, S. The occurrence of preterm delivery is linked to pregnancy-specific distress and elevated
inflammatory markers across gestation. Brain Behav. Immun. 2012, 26, 650–659. [CrossRef] [PubMed]
30. Crews, D.; Gillette, R.; Scarpino, S.V.; Manikkam, M.; Savenkova, M.I.; Skinner, M.K. Epigenetic
transgenerational inheritance of altered stress responses. Proc. Natl. Acad. Sci. USA 2012, 109, 9143–9148.
[CrossRef] [PubMed]
31. Zucchi, F.C.; Yao, Y.; Ward, I.D.; Ilnytskyy, Y.; Olson, D.M.; Benzies, K.; Kovalchuk, I.; Kovalchuk, O.;
Metz, G.A.S. Maternal stress induces epigenetic signatures of psychiatric and neurological diseases in the
offspring. PLoS ONE 2013, 8, e56967. [CrossRef] [PubMed]
32. Kaati, G.; Bygren, L.O.; Edvinsson, S. Cardiovascular and diabetes mortality determined by nutrition
during parents’ and grandparents’ slow growth period. Eur. J. Hum. Genet. 2002, 10, 682–688. [CrossRef]
[PubMed]
33. Franklin, T.B.; Linder, N.; Russig, H.; Thony, B.; Mansuy, I.M. Influence of early stress on social abilities and
serotonergic functions across generations in mice. PLoS ONE 2011, 6, e21842. [CrossRef] [PubMed]
34. Weiss, I.C.; Franklin, T.B.; Vizi, S.; Mansuy, I.M. Inheritable effect of unpredictable maternal separation on
behavioral responses in mice. Front. Behav. Neurosci. 2011, 5, 3. [CrossRef] [PubMed]
35. Ward, I.D.; Zucchi, F.C.; Robbins, J.C.; Falkenberg, E.A.; Olson, D.M.; Benzies, K.; Metz, G.A.
Transgenerational programming of maternal behaviour by prenatal stress. BMC Pregnancy Childbirth 2013,
13, S9. [CrossRef] [PubMed]
36. McFarlane, J.; Parker, B.; Soeken, K.; Bullock, L. Assessing for abuse during pregnancy. Severity and
frequency of injuries and associated entry into prenatal care. JAMA 1992, 267, 3176–3178. [CrossRef]
[PubMed]
37. Paris, J.J.; Frye, C.A. Gestational exposure to variable stressors produces decrements in cognitive and neural
development of juvenile male and female rats. Curr. Top. Med. Chem. 2011, 11, 1706–1713. [PubMed]
38. Herbison, A.E. Physiological roles for the neurosteroid allopregnanolone in the modulation of brain
function during pregnancy and parturition. Prog. Brain Res. 2001, 133, 39–47. [PubMed]
39. Chin, V.S.; van Skike, C.E.; Berry, R.B.; Kirk, R.E.; Diaz-Granados, J.; Matthews, D.B. Effect of acute ethanol
and acute allopregnanolone on spatial memory in adolescent and adult rats. Alcohol 2011, 45, 473–483.
[CrossRef] [PubMed]
40. Paris, J.J.; Frye, C.A. Juvenile offspring of rats exposed to restraint stress in late gestation have impaired
cognitive performance and dysregulated progestogen formation. Stress 2011, 14, 23–32. [PubMed]
29871
Int. J. Mol. Sci. 2015, 16, 29856–29874
41. McCreary, J.K.; Truica, L.S.; Friesen, B.; Yao, Y.; Olson, D.M.; Cross, A.R.; Metz, G.A.S. Recurrent
prenatal stress exacerbates stress sensitivity and vulnerability to mental illness across generations. 2015.
(submitted).
42. Knudson, A.G., Jr. Mutation and cancer: Statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA
1971, 68, 820–823. [CrossRef] [PubMed]
43. Olson, D.M.; (University of Alberta); McCreary, J.K.; (University of Lethbridge); Verstraeten, B.S.E.;
(University of Alberta); Metz, G.A.S.; (University of Lethbridge). Personal communication, 2015.
44. Yang, K.; Jones, S.A.; Challis, J.R. Changes in glucocorticoid receptor number in the hypothalamus and
pituitary of the sheep fetus with gestational age and after adrenocorticotropin treatment. Endocrinology
1990, 126, 11–17. [CrossRef] [PubMed]
45. Charil, A.; Laplante, D.P.; Vaillancourt, C.; King, S. Prenatal stress and brain development. Brain Res. Rev.
2010, 65, 56–79. [CrossRef] [PubMed]
46. Sarkar, S.; Tsai, S.W.; Nguyen, T.T.; Plevyak, M.; Padbury, J.F.; Rubin, L.P. Inhibition of placental
11β-hydroxysteroid dehydrogenase type 2 by catecholamines via α-adrenergic signaling. Am. J. Physiol.
Regul. Integr. Comp. Physiol. 2001, 281, R1966–R1974. [PubMed]
47. Newnham, J.P. Is prenatal glucocorticoid administration another origin of adult disease? Clin. Exp.
Pharmacol. Physiol. 2001, 28, 957–961. [CrossRef] [PubMed]
48. Seckl, J.R. Glucocorticoids, developmental “programming” and the risk of affective dysfunction. Prog.
Brain Res. 2008, 167, 17–34. [PubMed]
49. Kossintseva, I.; Wong, S.; Johnstone, E.; Guilbert, L.; Olson, D.M.; Mitchell, B.F. Proinflammatory cytokines
inhibit human placental 11β-hydroxysteroid dehydrogenase type 2 activity through Ca2+ and cAMP
pathways. Am. J. Physiol. Endocrinol. Metab. 2006, 290, E282–E288. [CrossRef] [PubMed]
50. Potestio, F.A.; Zakar, T.; Olson, D.M. Glucocorticoids stimulate prostaglandin synthesis in human amnion
cells by a receptor-mediated mechanism. J. Clin. Endocrinol. Metab. 1988, 67, 1205–1210. [CrossRef]
[PubMed]
51. Alfaidy, N.; Xiong, Z.G.; Myatt, L.; Lye, S.J.; MacDonald, J.F.; Challis, J.R. Prostaglandin F2α potentiates
cortisol production by stimulating 11β-hydroxysteroid dehydrogenase 1: A novel feedback loop that may
contribute to human labor. J. Clin. Endocrinol. Metab. 2001, 86, 5585–5592. [CrossRef] [PubMed]
52. Harris, A.; Seckl, J. Glucocorticoids, prenatal stress and the programming of disease. Horm. Behav. 2011, 59,
279–289. [CrossRef] [PubMed]
53. Migicovsky, Z.; Kovalchuk, I. Epigenetic memory in mammals. Front. Genet. 2011, 2, 28. [CrossRef]
[PubMed]
54. Zucchi, F.C.; Yao, Y.; Metz, G.A. The secret language of destiny: Stress imprinting and transgenerational
origins of disease. Front. Genet. 2012, 3, 96. [CrossRef] [PubMed]
55. Babenko, O.; Golubov, A.; Ilnytskyy, Y.; Kovalchuk, I.; Metz, G.A. Genomic and epigenomic responses to
chronic stress involve miRNA-mediated programming. PLoS ONE 2012, 7, e29441. [CrossRef] [PubMed]
56. Babenko, O.; Kovalchuk, I.; Metz, G.A. Stress-induced perinatal and transgenerational epigenetic
programming of brain development and mental health. Neurosci. Biobehav. Rev. 2015, 48, 70–91. [CrossRef]
[PubMed]
57. Challis, J.R.; Lockwood, C.J.; Myatt, L.; Norman, J.E.; Strauss, J.F., 3rd; Petraglia, F. Inflammation and
pregnancy. Reprod. Sci. 2009, 16, 206–215. [CrossRef] [PubMed]
58. Romero, R.; Dey, S.K.; Fisher, S.J. Preterm labor: One syndrome, many causes. Science 2014, 345, 760–765.
[CrossRef] [PubMed]
59. Breen, K.; Brown, A.; Burd, I.; Chai, J.; Friedman, A.; Elovitz, M.A. TLR-4-dependent and -independent
mechanisms of fetal brain injury in the setting of preterm birth. Reprod. Sci. 2012, 19, 839–850. [CrossRef]
[PubMed]
60. Hoang, M.; Potter, J.A.; Gysler, S.M.; Han, C.S.; Guller, S.; Norwitz, E.R.; Abrahams, V.M. Human fetal
membranes generate distinct cytokine profiles in response to bacterial Toll-like receptor and nod-like
receptor agonists. Biol. Reprod. 2014, 90, 39. [CrossRef] [PubMed]
61. Caballero-Campo, P.; Dominguez, F.; Coloma, J.; Meseguer, M.; Remohi, J.; Pellicer, A.; Simón, C. Hormonal
and embryonic regulation of chemokines IL-8, MCP-1 and RANTES in the human endometrium during the
window of implantation. Mol. Hum. Reprod. 2002, 8, 375–384. [CrossRef] [PubMed]
29872
Int. J. Mol. Sci. 2015, 16, 29856–29874
62. Van Mourik, M.S.; Macklon, N.S.; Heijnen, C.J. Embryonic implantation: Cytokines, adhesion molecules,
and immune cells in establishing an implantation environment. J. Leukoc. Biol. 2009, 85, 4–19. [CrossRef]
[PubMed]
63. McEwen, B.S. Stress, adaptation, and disease. Allostasis and allostatic load. Ann. N. Y. Acad. Sci. 1998, 840,
33–44. [CrossRef] [PubMed]
64. McEwen, B.S.; Wingfield, J.C. The concept of allostasis in biology and biomedicine. Horm. Behav. 2003, 43,
2–15. [CrossRef]
65. Shannon, M.; King, T.L.; Kennedy, H.P. Allostasis: A theoretical framework for understanding and
evaluating perinatal health outcomes. J. Obstet. Gynecol. Neonatal Nurs. 2007, 36, 125–134. [CrossRef]
[PubMed]
66. Elenkov, I.J.; Webster, E.L.; Torpy, D.J.; Chrousos, G.P. Stress, corticotropin-releasing hormone,
glucocorticoids, and the immune/inflammatory response: Acute and chronic effects. Ann. N. Y. Acad. Sci.
1999, 876, 1–11. [CrossRef] [PubMed]
67. Djuric, Z.; Bird, C.E.; Furumoto-Dawson, A.; Rauscher, G.H.; Ruffin, M.T.T.; Stowe, R.P.; Tucker, K.L.;
Masi, C.M. Biomarkers of Psychological Stress in Health Disparities Research. Open Biomark. J. 2008, 1,
7–19. [CrossRef] [PubMed]
68. Daskalakis, N.P.; Bagot, R.C.; Parker, K.J.; Vinkers, C.H.; de Kloet, E.R. The three-hit concept of vulnerability
and resilience: Toward understanding adaptation to early-life adversity outcome. Psychoneuroendocrinology
2013, 38, 1858–1873. [CrossRef] [PubMed]
69. Saban, K.L.; Mathews, H.L.; DeVon, H.A.; Janusek, L.W. Epigenetics and social context: Implications for
disparity in cardiovascular disease. Aging Dis. 2014, 5, 346–355. [PubMed]
70. Li, J.; Zhang, Y.; Li, D.; Liu, Y.; Chu, D.; Jiang, X. Small non-coding RNAs transfer through mammalian
placenta and directly regulate fetal gene expression. Protein Cell 2015, 6. [CrossRef] [PubMed]
71. Misra, D.P.; Straughen, J.K.; Slaughter-Acey, J.C. Allostatic load and health: Can perinatal epidemiology
lead the way forward? Paediatr. Perinat. Epidemiol. 2013, 27, 507–508. [CrossRef] [PubMed]
72. Nordling, C.O. A new theory on cancer-inducing mechanism. Br. J. Cancer 1953, 7, 68–72. [CrossRef]
[PubMed]
73. Spagnoli, C.; Cilio, M.R.; Pavlidis, E.; Pisani, F. Symptomatic neonatal seizures followed by febrile status
epilepticus: The two-hit hypothesis for the subsequent development of epilepsy. J. Child Neurol. 2015, 30,
615–618. [CrossRef] [PubMed]
74. Williams, H.J.; Monks, S.; Murphy, K.C.; Kirov, G.; O'Donovan, M.C.; Owen, M.J. Schizophrenia two-hit
hypothesis in velo-cardio facial syndrome. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2013, 162B, 177–182.
[CrossRef] [PubMed]
75. Racicot, K.; Kwon, J.Y.; Aldo, P.; Silasi, M.; Mor, G. Understanding the complexity of the immune system
during pregnancy. Am. J. Reprod. Immunol. 2014, 72, 107–116. [CrossRef] [PubMed]
76. McEwen, B.S. Interacting mediators of allostasis and allostatic load: Towards an understanding of resilience
in aging. Metabolism 2003, 52, 10–16. [CrossRef]
77. Seeman, T.E.; Singer, B.H.; Rowe, J.W.; Horwitz, R.I.; McEwen, B.S. Price of adaptation-allostatic load and
its health consequences. MacArthur studies of successful aging. Arch. Intern. Med. 1997, 157, 2259–2268.
[CrossRef] [PubMed]
78. Lu, M.C.; Halfon, N. Racial and ethnic disparities in birth outcomes: A life-course perspective.
Matern. Child Health J. 2003, 7, 13–30. [CrossRef] [PubMed]
79. Latendresse, G. The interaction between chronic stress and pregnancy: Preterm birth from a biobehavioral
perspective. J. Midwifery Women’s Health 2009, 54, 8–17. [CrossRef] [PubMed]
80. Power, M.L.; Schulkin, J. Maternal obesity, metabolic disease, and allostatic load. Physiol. Behav. 2012, 106,
22–28. [CrossRef] [PubMed]
81. Wallace, M.E.; Harville, E.W. Allostatic load and birth outcomes among white and black women in New
Orleans. Matern. Child Health J. 2013, 17, 1025102–1025109. [CrossRef] [PubMed]
82. Merkin, S.S.; Karlamangla, A.; Roux, A.V.; Shrager, S.; Seeman, T.E. Life course socioeconomic status and
longitudinal accumulation of allostatic load in adulthood: Multi-ethnic study of atherosclerosis. Am. J.
Public Health 2014, 104, e48–e55. [CrossRef] [PubMed]
29873
Int. J. Mol. Sci. 2015, 16, 29856–29874
83. Koopman, C.; Angell, K.; Turner-Cobb, J.M.; Kreshka, M.A.; Donnelly, P.; McCoy, R.; Turkseven, A.;
Graddy, K.; Giese-Davis, J.; Spiegel, D. Distress, coping, and social support among rural women recently
diagnosed with primary breast cancer. Breast J. 2001, 7, 25–33. [CrossRef] [PubMed]
84. Birkhoff, G. Lattice Theory, 4th ed.; American Mathematical Society Colloquium Publications: Providence,
RI, USA, 1979.
85. Wille, R. Line diagrams of hierarchical concept systems. Int. Classif. 1984, 11, 77–86.
86. Walker, L.O.; Avant, K.C. Concept analysis. In Strategies for Theory Construction in Nursing, 5th ed.; Prentice
Hall: Upper Sadle River, NJ, USA, 2011; pp. 157–179.
87. Erickson, Z.T.; Falkenberg, E.A.; Metz, G.A. Lifespan psychomotor behaviour profiles of multigenerational
prenatal stress and artificial food dye effects in rats. PLoS ONE 2014, 9, e92132. [CrossRef] [PubMed]
88. Karagiannides, I.; Golovatscka, V.; Bakirtzi, K.; Sideri, A.; Salas, M.; Stavrakis, D.; Polytarchou, C.;
Iliopoulos, D.; Pothoulakis, C.; Bradesi, S. Chronic unpredictable stress regulates visceral
adipocyte-mediated glucose metabolism and inflammatory circuits in male rats. Physiol. Rep. 2014,
2, e00284. [CrossRef] [PubMed]
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open
access article distributed under the terms and conditions of the Creative Commons by
Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
29874
